OncoMed Pharmaceuticals
Why Robinhood?
You can watch OMED and buy or sell other stocks, ETFs, and their options commission-free!About OMED
OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F.
OMED Key Statistics
Stock Snapshot
As of today, OncoMed Pharmaceuticals(OMED) shares are valued at $0.89. The company's market cap stands at 34.41M, with a P/E ratio of -4.21.
On 2026-03-03, OncoMed Pharmaceuticals(OMED) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for OncoMed Pharmaceuticals(OMED) stock has reached 0, versus its average volume of 1.23M.
Over the past 52 weeks, OncoMed Pharmaceuticals(OMED) stock has traded between a high of $3.35 and a low of $0.55.
Over the past 52 weeks, OncoMed Pharmaceuticals(OMED) stock has traded between a high of $3.35 and a low of $0.55.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.